Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05198765 · ClinicalTrials.gov registry record · NA
Weight Loss Clinical Decision Support
A NA study of Obesity and Diabetes Mellitus, Type 2, sponsored by HealthPartners Institute.
- Active
- Registry status
- NA
- Development phase
- 10,120
- Enrollment target
- 1
- Study location
NCT05198765 is a NA study of Obesity and Diabetes Mellitus, Type 2 that is active but no longer recruiting, run by HealthPartners Institute. The registered enrollment target is 10,120 participants, above the 809-participant average among 1,053 other Obesity trials with a reported enrollment target (1151% higher). The trial reports 1 study location across 1 state.
The verdict
NCT05198765, a NA study of Obesity and Diabetes Mellitus, Type 2, is active but no longer recruiting, sponsored by HealthPartners Institute.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 10,120 participants
- Enrollment target
- 1
- Study location
Study Summary
Despite steady increases in obesity prevalence, the more than 12 million obese U.S. adults with type 2 diabetes (T2DM) and severe obesity encounter a number of barriers to adopting effective surgical and pharmaceutical treatments, including: (a) both patients and primary care clinicians frequently underestimate the effectiveness and potential benefits of obesity treatments; and (b) both patients and clinicians typically lack access to evidence-based estimates of the patient-specific potential benefits and risks of appropriate obesity treatment options. This project addresses these important obstacles to evidence-based obesity care by providing accurate, patient-specific estimates of benefits and risks of various obesity treatment options to inform shared decision making about obesity treatment. In this project the study team will implement a scalable, web-based point-of-care decision-support intervention in primary care that provides patient-specific estimates of obesity treatment benefits and risks in a randomized trial in 40 primary care clinics with 15,810 eligible patients, and assess intervention impact on (i) appropriate active management of obesity in eligible patients, (ii) weight trajectories, and (iii) patient and clinician satisfaction with the decision support intervention.
Conditions Studied
Interventions
- BEHAVIORAL BMI-CDS
Study Locations (1)
Minnesota
- HealthPartners Medical Group - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10,120 participants |
| Start Date | 2023-04-19 |
| Est. Completion | 2026-04-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05198765
The ClinicalTrials.gov registry entry for NCT05198765 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 10,120 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 809-participant average among 1,053 other Obesity trials with a reported enrollment target (1151% higher). The listed sponsor is HealthPartners Institute, which has 146 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Obesity appearing as the primary indexed condition, and to 1 intervention - of which BMI-CDS is the first listed.
NCT05198765 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT05198765 about?
NCT05198765 is a clinical study titled "Weight Loss Clinical Decision Support". Despite steady increases in obesity prevalence, the more than 12 million obese U.S. adults with type 2 diabetes (T2DM) and severe obesity encounter a number of barriers to adopting effective surgical and pharmaceutical treatments, including: (a) both patients and primary care clinicians frequently u...
What is the current status of trial NCT05198765?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 10,120 participants. The study started on 2023-04-19. Estimated completion is 2026-04-30.
What conditions does trial NCT05198765 study?
This clinical trial studies the following conditions: Obesity, Diabetes Mellitus, Type 2.
What interventions are being tested in trial NCT05198765?
The interventions under investigation include: BMI-CDS (BEHAVIORAL).
Who is sponsoring clinical trial NCT05198765?
This trial is sponsored by HealthPartners Institute, which has 146 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05198765 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
RECRUITING · NA
-
Tai Chi as a Novel Strategy to Increase Physical Activity Among Adults Pursuing Metabolic and Bariatric Surgery
RECRUITING · NA
-
Mechanistic and Clinical Outcomes of a Surgical Innovation Aimed at Minimizing GERD Associated With VSG (INNOVATE-VSG)
RECRUITING · NA
-
SMARTer Weight Loss Management
RECRUITING · NA
-
HealthyTogether: RCT of a Dyadic Weight Management Intervention
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.